11:57AM ET 8/16/2022 MT NewswiresHomology Medicines (FIXX) has an average rating of outperform and price targets ranging from $3.21 to $20, according to analysts polled by Capital IQ. (MT...
6:54AM ET 8/16/2022 MT NewswiresHomology Medicines (FIXX) has an average rating of outperform and price targets ranging from $3.21 to $20, according to analysts polled by Capital IQ. (MT...
9:01AM ET 6/13/2022 MT NewswiresHomology Medicines (FIXX) said Monday that the US Food and Drug Administration has lifted a clinical hold on a trial of the company's HMI-102...
4:48AM ET 5/17/2022 MT NewswiresHomology Medicines (FIXX) has an average rating of outperform and price targets ranging from $4 to $29, according to analysts polled by Capital IQ. (MT...